🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A truly special moment at #IPPC2025 as we welcomed Pauline Meßner, a plasma donor from Germany. She shared what inspired her to donate, the rewarding feeling of helping others & how she spends her time while donating. Thanks to Britta Diebel for moderating this inspiring segment.

Session 6 at #IPPC2025 sparked rich discussions on building a resilient plasma supply chain. Stefaan Van der Spiegel, Milan Maly, Karmin Saadat, and Lorenzo Montrasio shared valuable insights. Thanks to Brad Pick for moderating this important conversation. #20YearsIPPC

Session 7 at #IPPC2025 tackled tough questions on national policies and their impact on access to plasma-derived medicines. Tobias Volkwein, Jakub Dvořáček, Adrian Goretzki, Anna Kostera-Pruszczyk, and Natalia Bartosik shared valuable insights. Thanks to Tomasz Kluszczyński for

✨Wrapping up #IPPC2025 ! An inspiring 2-day event filled with powerful stories and vital policy conversations, strengthening ties between donors, patients, advocates, HCPs, and researchers. Wonderful connecting with: 🔹 Pauline Meßner, plasma donor 🇩🇪 🔹 Martine Pergent & Leire

On 22 May, members of the PPTA Europe team met with Patricia Reilly, member of the office of Ursula von der Leyen, the President of the European Commission. During the conversation, PPTA highlighted the industry’s strong economic footprint in Europe, as well as the uniqueness of the

It's not too late to share your IPPC experience on social media! Use the official event hashtags #IPPC2025 or #20YearsIPPC on a social media recap post for a chance to win a gift card!

PPTA acknowledges EDQM's 22nd "Blood Guide" which offers key guidance on blood components. We commend EDQM's efforts for donor & patient safety but believe greater clarity on source plasma donation for fractionation would be beneficial. pptaglobal.org/material/ppta-…

Plasma-derived medicines are often the ONLY treatment for #rare diseases. Without access, patients risk: ▪️ Serious health complications ▪️ Physical limitations ▪️ Social isolation ▪️ Reduced quality of life Access to these #lifesaving treatments is CRITICAL!⬆️

PPTA is pleased to announce the appointment of Marilena Vrana as Vice President, Public Affairs & EU Operations. Marilena, who has led our EU Public Affairs since 2022, officially began her new role on 2 June. Read the full announcement below. ⬇️ pptaglobal.org/material/maril…

Life-saving plasma-derived medicines keep patients healthy & active, contributing to a more productive society for everyone. Consistent access is critical as patient clinical needs grow. Learn more: euneedsmoreplasma.com

The European Plasma Alliance (EPA) just released a statement on Czechia's new national plasma donor registry. Learn how this initiative supports donor safety and what EPA recommends moving forward. pptaglobal.org/material/epa-c…

A few weeks have passed since we gathered in Warsaw for #IPPC2025. If you missed it or want to revisit the highlights, our latest blog recaps the key takeaways and moments that made this 20th edition special. Catch up here: pptaglobal.org/material/exper…

June 28 is #InternationalNeonatalScreeningDay. PPTA proudly joins global efforts to raise awareness about the importance of neonatal screening programmes to address the unmet needs of children born with rare and treatable diseases. 📅 #INSD 🔗 Visit: neonatalscreeningday.org

The use of immunoglobulin (IG) treatments nearly doubled between 2009 and 2019. Check out some key factors driving the increased clinical need for plasma-derived medicines. 👇 #EUNeedsMorePlasma euneedsmoreplasma.com

The process of manufacturing plasma-derived medicinal products (PDMPs) takes much longer to produce than chemically-synthesized pharmaceutical medicines. It may take up to 12 months to manufacture PDMPs, from the moment the donation is made until it is ready to be given to a

50% of all source donated plasma in Europe is given by donors in only four countries: Austria, Czech Republic, Germany and Hungary, who mainly use plasmapheresis. Learn more: euneedsmoreplasma.com